日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference

推进非洲药物计量学发展:来自2025年非洲药物计量学大会的见解和展望

Adeagbo, Babatunde Ayodeji; Asiimwe, Innocent Gerald; Chaba, Linda; Kawuma, Aida N; Ojara, Francis Williams; Orherhe, Ochuko Maureen; Asiimwe, Simon Peter; Pillay-Fuentes Lorente, Veshni; Sawe, Sharon; Phogole, Cassius M; Waitt, Catriona; Mouksassi, Samer; Pillai, Goonaseelan Colin

Editorial: Digital health innovations in Africa: harnessing AI, telemedicine, and personalized medicine for improved healthcare

社论:非洲的数字医疗创新:利用人工智能、远程医疗和个性化医疗改善医疗保健

Benecke, Rohan M; Asiimwe, Innocent G; Abulfathi, Ahmed A; Mouksassi, Samer; Rosenkranz, Bernd

Advancing pharmacometrics in Africa-Transition from capacity development toward job creation

推进非洲的药物计量学发展——从能力建设转向创造就业机会

Pillai, Goonaseelan Colin; Mouksassi, Samer; Asiimwe, Innocent G; Rayner, Craig R; Kern, Steven; Sinxadi, Phumla; Denti, Paolo; Decloedt, Eric; Waitt, Catriona; Ogutu, Bernhards R; de Greef, Rik

Postmarketing Assessment of Antibody-Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

抗体药物偶联物上市后评估:基于模型的荟萃分析和临床实用指数方法的概念验证

Asiimwe, Innocent Gerald; Chtiba, Nour; Mouksassi, Samer; Pillai, Goonaseelan Colin; Peter, Raimund M; Yuen, Eunice; Pilla Reddy, Venkatesh

Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d'Ivoire

了解药物暴露与鞭虫病治愈率:坦桑尼亚和科特迪瓦阿苯达唑-伊维菌素联合用药的药代动力学方法

Pillay-Fuentes Lorente, Veshni; Nwogu-Attah, Jacinta N; Steffens, Britta; Bräm, Dominic; Sprecher, Viviane; Hofmann, Daniela; Buettcher, Michael; Pillai, Goonaseelan; Mouksassi, Samer; Coulibaly, Jean; Pfister, Marc; Keiser, Jennifer

Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?

关于新冠肺炎现有疗法有效性的全面证据:我们能否将真实世界研究与随机对照试验结合起来?

Mandema, Jaap; Montgomery, Hugh; Dron, Louis; Fu, Shuai; Russek-Cohen, Estelle; Bromley, Christina; Mouksassi, Samer; Lalonde, Amy; Springford, Aaron; Tsai, Larry; Ambery, Phil; McNair, Doug; Qizilbash, Nawab; Pocock, Stuart; Zariffa, Névine

Corrigendum to: 2022 WCoP Abstracts

更正:2022 年 WCoP 摘要

Marier, Jean-Francois; Teuscher, Nathan; Mouksassi, Mohamad-Samer

Infections in Hematology Patients

血液病患者的感染

Chain, Anne; Wrishko, Rebecca; Vasilinin, Grygoriy; Mouksassi, Samer; Nesher, Lior; Rolston, Kenneth V I; Blennow, Ola; Ljungman, Per

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

肾脏总体积是常染色体显性多囊肾病患者肾功能下降和进展至终末期肾病的预后生物标志物

Perrone, Ronald D; Mouksassi, Mohamad-Samer; Romero, Klaus; Czerwiec, Frank S; Chapman, Arlene B; Gitomer, Berenice Y; Torres, Vicente E; Miskulin, Dana C; Broadbent, Steve; Marier, Jean F

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease

用于提高常染色体显性多囊肾病患者临床试验入组的药物研发工具

Perrone, Ronald D; Mouksassi, Mohamad-Samer; Romero, Klaus; Czerwiec, Frank S; Chapman, Arlene B; Gitomer, Berenice Y; Torres, Vicente E; Miskulin, Dana C; Broadbent, Steve; Marier, Jean F